Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 1/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.55 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.53 |
| ▸ | LDHA | P00338 | 1/20 | 0.52 |
| ▸ | COMT | P21964 | 1/20 | 0.52 |
| ▸ | AURKA | O14965 | 1/20 | 0.52 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.52 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.49 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.49 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.49 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.49 |
| ▸ | MPL | P40238 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | SUMO2 | P61956 | 2/20 | 0.44 |
| ▸ | SUMO1 | P63165 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29409575 | 1.00 | TTR (0.61) | TTRCYP1A2CTRB1LDHACOMT | |
| SCHEMBL7710380 | 0.97 | TTR (0.59) | TTRCYP1A2CTRB1LDHACOMT | |
| Hydrochloric Acid SCHEMBL11157253 | 0.97 | TTR (0.59) | TTRCYP1A2CTRB1LDHACOMT | |
| SCHEMBL30233642 | 0.89 | TTR (0.75) | TTRCYP1A2CTRB1COMTAURKA | |
| SCHEMBL29363198 | 0.89 | TTR (0.75) | TTRCYP1A2CTRB1COMTAURKA | |
| SCHEMBL6242 | 0.89 | TTR (0.75) | TTRCYP1A2CTRB1COMTAURKA | |
| SCHEMBL29564390 | 0.89 | LDHA (0.70) | TTRCYP1A2CTRB1LDHACOMT | |
| SCHEMBL249254 | 0.89 | LDHA (0.70) | TTRCYP1A2CTRB1LDHACOMT | |
| SCHEMBL1804533 | 0.89 | TTR (0.52) | TTRCYP1A2CTRB1LDHACOMT | |
| Ammonia Solution, Strong SCHEMBL16413079 | 0.87 | LDHA (0.68) | TTRCYP1A2CTRB1LDHACOMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 384 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260126724-A1 | SEMICONDUCTOR PHOTORESIST COMPOSITION AND METHOD OF FORMING PATTERNS USING THE COMPOSITION | SAMSUNG SDI CO., LTD. (KR) | 2026-05-07 | — | — | US | claimed |
| US-20260063995-A1 | SEMICONDUCTOR PHOTORESIST COMPOSITIONS AND METHODS OF FORMING PATTERNS USING THE COMPOSITIONS | SAMSUNG SDI CO LTD (KR) | 2026-03-05 | — | — | US | claimed |
| US-20240393684-A1 | METHOD OF FORMING PATTERNS | SAMSUNG SDI CO., LTD. (KR) | 2024-11-28 | — | — | US | claimed |
| CN-105061775-B | It is a kind of that the method for preparing new fluorescent organic solid material is assembled by Cucurbituril anion | 大连理工大学 | 2017-08-01 | — | — | CN | claimed |
| CN-106279127-A | Afatinib acid-addition salts and crystal formation, its preparation method and pharmaceutical composition | 杭州普晒医药科技有限公司 | 2017-01-04 | — | — | CN | claimed |
| CN-102417839-A | Fuel antistatic agent and application thereof | OIL RES INST OF THE AIR FORCE PLA | 2012-04-18 | — | — | CN | claimed |
| CN-1103533-A | Biologically active ureido derivatives useful as anti-metastatic agents | ERBA CARLO SPA (IT) | 1995-06-07 | — | — | CN | claimed |
| EP-0639073-A1 | BIOLOGICALLY ACTIVE UREIDO DERIVATIVES USEFUL AS ANTIMETASTATIC AGENTS | PHARMACIA & UPJOHN S.p.A. (IT) | 1995-02-22 | — | — | EP | claimed |
| WO-1994020095-A1 | BIOLOGICALLY ACTIVE UREIDO DERIVATIVES USEFUL AS ANTIMETASTATIC AGENTS | FARMITALIA CARLO ERBA S.R.L. (IT) | 1994-09-15 | — | — | WO | claimed |
| JP-1042453-A | — | — | None | — | — | JP | disclosed |
| US-20260147273-A1 | SEMICONDUCTOR PHOTORESIST COMPOSITION AND METHOD OF FORMING PATTERNS USING THE COMPOSITION | SAMSUNG SDI CO., LTD. (KR) | 2026-05-28 | — | — | US | disclosed |
| US-20260140441-A1 | SEMICONDUCTOR PHOTORESIST COMPOSITION AND METHOD OF FORMING PATTERNS USING THE COMPOSITION | SAMSUNG SDI CO LTD (KR) | 2026-05-21 | — | — | US | disclosed |
| US-20260133484-A1 | SEMICONDUCTOR PHOTORESIST COMPOSITION AND METHOD OF FORMING PATTERNS USING THE COMPOSITION | SAMSUNG SDI CO LTD (KR) | 2026-05-14 | — | — | US | disclosed |
| US-20260133487-A1 | SEMICONDUCTOR PHOTORESIST COMPOSITION AND METHOD OF FORMING PATTERNS USING THE COMPOSITION | SAMSUNG SDI CO LTD (KR) | 2026-05-14 | — | — | US | disclosed |
| US-4087245-A | Process for the preparation of concentrated solutions of anionic dyestuffs | BAYER AKTIENGESELLSCHAFT (DT) | 1978-05-02 | — | — | US | disclosed |
| US-4062837-A | Disazo compounds useful as complement inhibitors | AMERICAN CYANAMID COMPANY (US) | 1977-12-13 | — | — | US | disclosed |
| US-4060628-A | 2-(Alkylhalophenylimino)dithiolanes and ectoparasiticidal composition and method | BAYER AKTIENGESELLSCHAFT (DT) | 1977-11-29 | — | — | US | disclosed |
| US-4017484-A | Cationic dyestuffs | BAYER AKTIENGESELLSCHAFT (DT) | 1977-04-12 | — | — | US | disclosed |
| US-3992405-A | ESPECIALLY FOR DYEING POLYACRYLIC FIBERS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-11-16 | — | — | US | disclosed |
| US-3956333-A | BACTERICIDE | STERLING DRUG INC. (US) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260133484-A1 | SEMICONDUCTOR PHOTORESIST COMPOSITION AND METHOD OF FORMING PATTERNS USING THE COMPOSITION | C1S, C5, YAP1 | TTR 3967/4885CYP1A2 158/4885CTRB1 4359/4885 |
| US-20260147273-A1 | SEMICONDUCTOR PHOTORESIST COMPOSITION AND METHOD OF FORMING PATTERNS USING THE COMPOSITION | ADH1A, C1S, ADH1C | TTR 1567/4885CYP1A2 90/4885CTRB1 4304/4885 |
| US-20260133487-A1 | SEMICONDUCTOR PHOTORESIST COMPOSITION AND METHOD OF FORMING PATTERNS USING THE COMPOSITION | CCND1, EEF1D, RPS4Y1 | TTR 3725/4885CYP1A2 1690/4885CTRB1 4143/4885 |
| US-20260126724-A1 | SEMICONDUCTOR PHOTORESIST COMPOSITION AND METHOD OF FORMING PATTERNS USING THE COMPOSITION | SCO2, CLTB, HCCS | TTR 2572/4885CYP1A2 1044/4885CTRB1 334/4885 |
| US-20260140441-A1 | SEMICONDUCTOR PHOTORESIST COMPOSITION AND METHOD OF FORMING PATTERNS USING THE COMPOSITION | SCO2, RPS3A, RPS4Y1 | TTR 1820/4885CYP1A2 704/4885CTRB1 1034/4885 |
| US-20260063995-A1 | SEMICONDUCTOR PHOTORESIST COMPOSITIONS AND METHODS OF FORMING PATTERNS USING THE COMPOSITIONS | ETV6, RPS4Y1, ETV1 | TTR 2506/4885CYP1A2 490/4885CTRB1 3407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.